Amsterdam UMC proudly presents new spin-off Kling BioTherapeutics
November 18, 2021Kling BioTherapeutics is a newly-formed Amsterdam UMC spin-off that is discovering and developing innovative antibody and antibody-derived drugs to treat cancer and infectious disease patients. With its lead program preparing to enter human clinical trials, Kling is well positioned to become an immuno-oncology biotech leader with a
novel discovery platform and a robust pipeline of first in class oncology antibodies. Amsterdam UMC has partnered with U.S.-based venture capital firm Time BioVentures to build Kling, and is excited by the company’s rapid progress in attracting a world-class management team of seasoned drug development executives with impressive track records bringing breakthrough products to patients. The company’s offices and labs are located on Amsterdam UMC’s Meibergdreef campus.
More news
Pilot call 2024 for Amsterdam UMC TKI-grants is now open!
The grant amounts available to both AMC and VUmc will of course be combined again, creating a budget of approximately € 4 million that will be divided over the best PPP-research proposals that we will receive from all of you. Deadline for the pre-application is May 24.
News
New investment in VU spin-off Rapid Photonics for even faster internet
Rapid Photonics receives funding from Innovatiefonds Noord-Holland for the development of an innovative production process of photonic chips with lithium niobate. Rapid Photonics B.V. is a spin-off of the Vrije Universiteit Amsterdam. Through the new convertible loan of €300,000, the company will be getting their technology market-ready to produce integrated photonic chips with lithium niobate, […]
News
Four Amsterdam researchers admitted to NWO’s Faculty of Impact
In the Life Sciences & Health round, 14 researchers have been selected for the Faculty of Impact programme for two years of intensive and personal guidance in entrepreneurship, intellectual property and investment. Four Amsterdam based researchers have been selected as well: Anouk Post (VU), Olivier Lugier (UvA), Felix Paulußen (VU) and Ewelina Weglarz-Tomczak (UvA). A […]
News